Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A comparative study of Serum ALT levels in metabolic syndrome patients with and without NAFLD

View through CrossRef
Background: This study was undertaken to evaluate the Serum ALT levels in MetS patients with and without NAFLD. The objective was to compare the change in serum ALT levels in those patients. Methods: The study was conducted in the Department of Biochemistry in association with Department of Medicine, National Institute of Medical Sciences and Hospital, Jaipur. At the same time adult diagnosed 150 MetS patients (75 without NAFLD & 75 with NAFLD) were taken. Anthropometric measurements were taken. ALT was measured in serum in both groups. The data obtained was statistically analysed. Results: Serum ALT was 67.89 ± 36.26 U/l in MetS with NAFLD while it was 46.03 ± 8.99 U/l in without NAFLD. Conclusions: increased ALT level is highly significant (p value < 0.001) in MetS with NAFLD as compare to without NAFLD. So increase in ALT in blood is associated with NAFLD in MetS patients.
Title: A comparative study of Serum ALT levels in metabolic syndrome patients with and without NAFLD
Description:
Background: This study was undertaken to evaluate the Serum ALT levels in MetS patients with and without NAFLD.
The objective was to compare the change in serum ALT levels in those patients.
Methods: The study was conducted in the Department of Biochemistry in association with Department of Medicine, National Institute of Medical Sciences and Hospital, Jaipur.
At the same time adult diagnosed 150 MetS patients (75 without NAFLD & 75 with NAFLD) were taken.
Anthropometric measurements were taken.
ALT was measured in serum in both groups.
The data obtained was statistically analysed.
Results: Serum ALT was 67.
89 ± 36.
26 U/l in MetS with NAFLD while it was 46.
03 ± 8.
99 U/l in without NAFLD.
Conclusions: increased ALT level is highly significant (p value < 0.
001) in MetS with NAFLD as compare to without NAFLD.
So increase in ALT in blood is associated with NAFLD in MetS patients.

Related Results

Association of Lipid Profile Abnormalities with NAFLD Severity in Patients with Metabolic Syndrome
Association of Lipid Profile Abnormalities with NAFLD Severity in Patients with Metabolic Syndrome
Background: Nonalcoholic fatty liver disease (NAFLD) is becoming a significant global health issue, and it is frequently associated with metabolic conditions, including hypertensio...
Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
Abstract Background: ALT value is often used to reflect the hepatic inflammation and injury in NAFLD patients, but many studies proved that ALT values were normal in many N...
Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
Abstract Background ALT value is often used to reflect hepatic inflammation and injury in NAFLD patients, but many studies suggested that ALT values are normal in many NAFL...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Metabolic dysfunction–associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease
Metabolic dysfunction–associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease
The term metabolic dysfunction–associated fatty liver disease (MAFLD) has been proposed based on a redefinition of the nonalcoholic fatty liver disease (NAFLD) criteria. Our study ...
Decreased Serum zinc, selenium, and vitamin E as possible risk factors of hepatic fibrosis in non-alcoholic fatty liver disease
Decreased Serum zinc, selenium, and vitamin E as possible risk factors of hepatic fibrosis in non-alcoholic fatty liver disease
Backgrounds The incidence of non-alcoholic fatty liver disease (NAFLD) has been significantly growing in recent years. Although the pathophysiology of fibrosis progression in NAFLD...

Back to Top